The current study provides specific molecular data in GBM models suggesting a dual effect on stemness-associated transcripts and a key chemoresistance gene, MGMT, warranting further investigation into how these transcriptional changes translate to functional sensitization. The gene discussed is MGMT; the disease is glioblastoma.